Brainify.AI logo

Brainify.AI

AI biomarker platform for a novel treatment developed for depression. Part of J&J Jlabs and Merck DSS.

11 employees · est. 2021 · New York, United States

VS
Denovo Biopharma logo

Denovo Biopharma

29 employees · est. 2011 · San Diego, United States

Denovo Biopharma is the older company (2021 vs 2011).

Side-by-Side Comparison

Brainify.AI Denovo Biopharma
Founded
2021 2011 older
Headquarters
New York, United States San Diego, United States
Employees
11 29
Industry
AI, Health Care, Pharmaceutical Biopharma, Biotechnology, Health Care
Funding Stage
Pre Seed Grant
Total Funding
$1.60M $1.20B
Funding Rounds
6 5
Services
Developing and applying AI models for precision neuroscience, analyzing brain data to identify EEG biomarkers for neurological disorders and drug development. Not tracked yet
Target Customers
Clinics, pharmaceutical companies, research institutions, and professionals in the healthcare and neuroscience fields. Not tracked yet
Taxonomy
AI Biomarker Platform, Depression Treatment, Drug Development, AI/ML, EEG Biomarker, Clinical Trials, R&D Efficiency, Patient Outcomes, PlaceboInsight AI, TherapyInsight AI, CleanSpectrum AI, Pharmaceutical Innovation, Investment Backed, Clinical Data Analysis Biomarker Discovery, Personalized Medicine, Drug Development, Genomic Analysis, Clinical Trials, Biotech, Pharmaceuticals, Oncology, Neurological Diseases, Late-stage Clinical Trials, Retrospective Analysis, Patient Responsiveness, Therapeutic Areas, China Operations, Algorithm
Website
brainify.ai denovobiopharma.com
Brainify.AI logo

About Brainify.AI

Brainify.AI, founded in 2021, is revolutionizing the pharmaceutical landscape with its cutting-edge AI biomarker platform. This innovation, designed specifically for the development of novel treatments for depression, is positioned to enhance the likelihood of new treatment approvals and boost drug...

Denovo Biopharma logo

About Denovo Biopharma

Denovo Biopharma is a San Diego-based biotech company with operations in China that specializes in providing a unique biomarker solution to personalize drug development. Founded in 2011, the company has developed an industry-first platform and algorithm for de novo genomic biomarker discovery using...

We will tell you when either one moves

BounceWatch watches Brainify.AI and Denovo Biopharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Brainify.AI and Denovo Biopharma — by email.

Frequently Asked Questions

Brainify.AI — AI biomarker platform for a novel treatment developed for depression. Part of J&J Jlabs and Merck DSS.. Denovo Biopharma. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Brainify.AI has raised $1.60M while Denovo Biopharma has raised $1.20B.
Brainify.AI and Denovo Biopharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Brainify.AI with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Brainify.AI on 29 May 2025, and Denovo Biopharma on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy